Andrew Sinclair Transaction History

Date Transaction Value Shares Traded Form
Jul 01 2022
SELL
Sale (or disposition) back to the issuer
$72,276,985 $55.0 p/Share
1,314,127
Jan 31 2022
BUY
Open market or private purchase
$4,050,000 $27.0 p/Share
150,000
Jan 28 2022
BUY
Exercise of in-the-money or at-the-money derivatives securities
$3,794,617 $13.2 p/Share
287,471

Also insider at

SLNO
SOLENO THERAPEUTICS INC Healthcare
ACET
Adicet Bio, Inc. Healthcare
VRNA
Verona Pharma plc Healthcare
AS

Andrew Sinclair

Director
Redwood City, CA

Track Institutional and Insider Activities on SRRA

Follow Sierra Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRRA shares.

Notify only if

Insider Trading

Get notified when an Sierra Oncology, Inc. insider buys or sells SRRA shares.

Notify only if

News

Receive news related to Sierra Oncology, Inc.

Track Activities on SRRA